Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional …

SG Smith, SMC Green, R Ellison, R Foy, CD Graham… - BMJ open, 2023 - bmjopen.bmj.com
Introduction Women with breast cancer who do not adhere to adjuvant endocrine therapy
(AET) have increased risks of mortality and recurrence. There are multiple barriers to AET …

Supporting endocrine therapy adherence in women with breast cancer: findings from the ROSETA pilot fractional factorial randomized trial

SG Smith, SMC Green, E McNaught… - Annals of Behavioral …, 2025 - academic.oup.com
Background Adherence to adjuvant endocrine therapy (AET) in women with breast cancer is
poor. Multicomponent intervention packages are needed to address adherence barriers …

Assessing multidimensional fidelity in a pilot optimization trial: A process evaluation of four intervention components supporting medication adherence in women with …

SMC Green, CD Graham, M Collinson… - Translational …, 2025 - academic.oup.com
Adherence to adjuvant endocrine therapy in women with breast cancer is low. We
conducted a 24-1 fractional factorial pilot optimization trial to test four intervention …

Acceptability of four intervention components supporting medication adherence in women with breast cancer: a process evaluation of a fractional factorial pilot …

SMC Green, N Rousseau, LH Hall, DP French… - Prevention …, 2024 - Springer
Adjuvant endocrine therapy (AET) reduces mortality in early-stage breast cancer, but
adherence is low. We developed a multicomponent intervention to support AET adherence …

Development of a Cancer Pathway Support Guide for Patients and Carers: A Codesign Project

A Bhuiya, S Cavanagh, C Nestor… - European Journal of …, 2024 - Wiley Online Library
Background. Cancer diagnosis is a complex and multifaceted process that can be stressful
and anxiety‐provoking for patients. Evidence‐based tools and information aids that can be …

[HTML][HTML] Protocol: Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for …

SG Smith, SMC Green, R Ellison, R Foy, CD Graham… - BMJ Open, 2023 - ncbi.nlm.nih.gov
Introduction Women with breast cancer who do not adhere to adjuvant endocrine therapy
(AET) have increased risks of mortality and recurrence. There are multiple barriers to AET …